Thursday, 19 July 2018 - 7:03
  • it
  • de
  • en
  • fr


Psoriasis: positive opinion in Europe on Almirall’s Skilarence

EMA Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion, recommending a marketing authorization for Almirall’s Skilarence, for the treatment of psoriasis. The product will be available as 30-mg and 120-mg gastro-resistant tablets. Its active ingredient…